Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Genomics Ltd is a leading biotechnology company at the forefront of genomic research and its application in healthcare. We specialize in high-throughput DNA sequencing, bioinformatics analysis, and the development of novel diagnostic and therapeutic strategies based on genomic insights. Our mission is to unlock the complexities of the genome to improve human health, driving innovation in personalized medicine, rare disease diagnosis, oncology, and pharmacogenomics. We collaborate with academic institutions, pharmaceutical companies, and healthcare providers to translate cutting-edge research into real-world solutions.
The Cambridge headquarters serves as the central node for our research and development, corporate strategy, global operations management, and administrative functions.
Our HQ features state-of-the-art sequencing laboratories, advanced bioinformatics computation facilities, collaborative workspaces, and a dedicated innovation incubator.
The work culture at our Cambridge HQ is dynamic, collaborative, and science-driven. We foster an environment of intellectual curiosity, continuous learning, and mutual respect, encouraging cross-functional teamwork to solve complex challenges.
Its location within the Cambridge biotech cluster provides unparalleled access to top-tier talent, leading research institutions, potential collaborators, and a vibrant ecosystem of innovation.
Genomics Ltd operates globally, supporting research, clinical, and commercial activities across North America, Europe, and Asia-Pacific. Our key functions, including advanced R&D, bioinformatics, sales and marketing, technical support, and strategic partnerships, are distributed across our international offices to effectively serve our diverse clientele and collaborate with the global scientific community.
BioInnovation Hub, 789 Genome Drive
Cambridge
Cambridgeshire
United Kingdom
Address: Kendall Square, Suite 550, 1 Rogers Street, Cambridge, MA 02142, USA
To expand market penetration in North America, facilitate partnerships with leading US research institutions, and support clinical trial activities.
Address: Biopolis Research Park, #08-01 Nucleos, 21 Biopolis Road, Singapore 138567
To serve the growing demand for genomic services in the APAC region, foster local research partnerships, and navigate diverse regulatory landscapes.
Address: Technologiepark Heidelberg, Im Neuenheimer Feld 582, 69120 Heidelberg, Germany
To offer specialized bioinformatics services to the European market and strengthen research ties with continental European academic and industry partners.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Genomics' leadership includes:
Genomics has been backed by several prominent investors over the years, including:
Genomics Ltd has seen strategic additions to its executive team over the past year, strengthening its operational and technological leadership, with one notable departure due to retirement.
Discover the tools Genomics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Genomics Ltd commonly uses the email format of the employee's first initial followed by their last name. Variations might exist for common names or specific departments.
f[last]@genomics-ltd-example.com (e.g., jsmith@genomics-ltd-example.com) or [first].[last]@genomics-ltd-example.com
Format
athorne@genomics-ltd-example.com
Example
90%
Success rate
GenomeWeb • May 20, 2024
Genomics Ltd announced a significant expansion of its Next-Generation Sequencing (NGS) capabilities at its Cambridge headquarters. This includes the acquisition of new high-throughput sequencing platforms and an upgrade to its bioinformatics infrastructure, aiming to double its processing capacity for large-scale genomic projects....more
Fierce Biotech • April 15, 2024
Genomics Ltd has partnered with AI specialist OncoInnovate to leverage artificial intelligence and machine learning for identifying novel therapeutic targets in oncology. The collaboration will combine Genomics Ltd's extensive genomic datasets with OncoInnovate's AI platform to accelerate drug discovery pipelines....more
European Pharmaceutical Review • February 28, 2024
Genomics Ltd has officially opened its new European bioinformatics and data analysis center in Heidelberg, Germany. This facility will enhance its service capabilities for European clients and research partners, focusing on secure and advanced computational biology....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Genomics, are just a search away.